Skip to main content

Table 5 Results of the response of experimental Box–Behnken design for optimization of NDFX-loaded transethosomes

From: A DoE-based development and characterization of Nadifloxacin-loaded transethosomal gel for the treatment of Acne vulgaris

Formulation code

PC 90 (%)

Tween 80 (%)

Ethanol (%)

Entrapment (%)

Vesicle size (nm)

Zeta potential (mV)

1

2

0.3

30

54.71

100.65

 − 32.25

2

3

0.3

25

73.89

128.2

 − 27.88

3

3

0.2

20

80.76

173.01

 − 33.72

4

2

0.4

25

57.7

97.12

 − 34.34

5

3

0.3

25

74.01

128.9

 − 29.98

6

3

0.4

20

72.73

142.25

 − 29.99

7

3

0.3

25

74.48

128.6

 − 30.25

8

3

0.3

25

73.61

126.9

 − 29.77

9

3

0.2

30

71.61

134.9

 − 27.74

10

4

0.3

30

67.48

142.21

 − 22.43

11

3

0.4

30

43.64

96.74

 − 24.72

12

4

0.3

20

79.6

188.51

 − 19.95

13

2

0.2

25

72.82

151.18

 − 29.2

14

3

0.3

25

73.73

138.3

 − 28.35

15

2

0.3

20

79.95

156.96

 − 34.18

16

4

0.2

25

81.05

187.34

 − 21.51

17

4

0.4

25

63.72

160.17

 − 17.12